Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin.

Agata Turlej-Rogacka, Basil Britto Xavier, Lore Janssens, Christine Lammens, Olympia Zarkotou, Spyros Pournaras, Herman Goossens, Surbhi Malhotra-Kumar
Author Information
  1. Agata Turlej-Rogacka: Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  2. Basil Britto Xavier: Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  3. Lore Janssens: Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  4. Christine Lammens: Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  5. Olympia Zarkotou: Department of Microbiology, Medical School, University of Athens, Athens, Greece.
  6. Spyros Pournaras: Department of Microbiology, Medical School, University of Athens, Athens, Greece.
  7. Herman Goossens: Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  8. Surbhi Malhotra-Kumar: Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. surbhi.malhotra@uantwerpen.be. ORCID

Abstract

Susceptibility testing for colistin remains challenging primarily due to its inherent properties. We evaluated colistin stability in agar and reproducibility of colistin MICs obtained by agar dilution, broth macro- and micro-dilution and MIC gradient strips on 3-7 iterations of each method using clinical Klebsiella pneumoniae (susceptible-CS, and resistant-CR, n = 2 each), mcr-harboring Escherichia coli (n = 2), and reference strains E. coli ATCC25922 and Pseudomonas aeruginosa ATCC27853. MICs for reference strains were not in the given range using Etest and broth microdilution (ATCC25922, 0.125 and 4 μg/ml, respectively). MICs of CR-1 and CR-2, and of the mcr-harboring E. coli showed high concordance between agar and broth dilution varying up to one 2-fold dilution. However, remarkable variations were observed on broth dilution with CS-1 and CS-2 (MIC range 0.25-32 and 0.5-64 μg/ml, respectively); whereas for agar dilution the MIC for both CS strains was 0.5 μg/ml in all the runs. MICs obtained by MIC gradient strips were lower than those obtained by dilution methods (1-2 dilutions for CS and mcr strains, and up to five dilutions for CR strains). To confirm uniform distribution of colistin in agar, a single strain was spotted in five different regions of the same plate. All spots showed concordant growth with maximum one dilution difference. No effect on MIC was found due to storage of colistin-containing agar plates for 7 days at 4 °C. In our hands, agar dilution was superior in terms of reproducibility and robustness, compared to broth dilution methods, for colistin MIC determination.

Keywords

References

  1. J Clin Microbiol. 2005 Feb;43(2):903-5 [PMID: 15695701]
  2. Antimicrob Agents Chemother. 2007 Jan;51(1):376-8 [PMID: 17043112]
  3. Euro Surveill. 2016 Jul 7;21(27): [PMID: 27416987]
  4. Lett Appl Microbiol. 2011 Nov;53(5):546-51 [PMID: 21895730]
  5. J Antimicrob Chemother. 2010 Jul;65(7):1416-23 [PMID: 20430789]
  6. Pharmacotherapy. 2015 Jan;35(1):22-7 [PMID: 25329490]
  7. J Clin Microbiol. 2013 Dec;51(12):4106-11 [PMID: 24088860]
  8. Clin Infect Dis. 2017 Mar 15;64(6):711-718 [PMID: 27940944]
  9. Antimicrob Agents Chemother. 2007 Oct;51(10):3726-30 [PMID: 17646414]
  10. J Clin Microbiol. 2013 Jun;51(6):1924-6 [PMID: 23536402]
  11. Diagn Microbiol Infect Dis. 2012 Dec;74(4):412-4 [PMID: 23102558]
  12. Lancet Infect Dis. 2016 Feb;16(2):161-8 [PMID: 26603172]
  13. J Clin Microbiol. 2016 May;54(5):1395-9 [PMID: 26984971]
  14. J Clin Microbiol. 2013 Jun;51(6):1678-84 [PMID: 23486719]
  15. Clin Microbiol Rev. 2017 Apr;30(2):557-596 [PMID: 28275006]
  16. J Antimicrob Chemother. 2006 Oct;58(4):864-7 [PMID: 16905528]
  17. J Clin Microbiol. 2001 Jan;39(1):183-90 [PMID: 11136768]
  18. Clin Microbiol Infect. 2007 May;13(5):541-4 [PMID: 17371537]
  19. Int J Antimicrob Agents. 2008 May;31(5):434-9 [PMID: 18328674]
  20. Antimicrob Agents Chemother. 2009 Oct;53(10):4345-51 [PMID: 19635950]
  21. Antimicrob Agents Chemother. 2015 Aug;59(8):4625-30 [PMID: 26014928]

Grants

  1. 282512/EU-FP7
  2. 2012-27450/Universiteit Antwerpen BOF-DOCPRO

MeSH Term

Agar
Anti-Bacterial Agents
Colistin
Disk Diffusion Antimicrobial Tests
Drug Resistance, Multiple, Bacterial
Escherichia coli
Humans
Klebsiella pneumoniae
Pseudomonas aeruginosa

Chemicals

Anti-Bacterial Agents
Agar
Colistin

Word Cloud

Created with Highcharts 10.0.0dilutionagarcolistinMICbrothstrainsMICs0testingobtainedcolimethodsSusceptibilityduestabilityreproducibilitygradientstripsusingn = 2mcr-harboringreferenceEATCC25922rangeEtestmicrodilutionrespectivelyshowedoneCSdilutionsfiveBrothremainschallengingprimarilyinherentpropertiesevaluatedmacro-micro-dilution3-7iterationsmethodclinicalKlebsiellapneumoniaesusceptible-CSresistant-CREscherichiaPseudomonasaeruginosaATCC27853given1254 μg/mlCR-1CR-2highconcordancevarying2-foldHoweverremarkablevariationsobservedCS-1CS-225-325-64 μg/mlwhereas5 μg/mlrunslower1-2mcrCRconfirmuniformdistributionsinglestrainspotteddifferentregionsplatespotsconcordantgrowthmaximumdifferenceeffectfoundstoragecolistin-containingplates7 days4 °ChandssuperiortermsrobustnesscompareddeterminationEvaluationcomparisonfourAgarmacrodilutionE-testHeteroresistancePolymyxinsReproducibilitySkipwellsStability

Similar Articles

Cited By